{"id":"NCT00954447","sponsor":"Boehringer Ingelheim","briefTitle":"Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes","officialTitle":"A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group Efficacy and Safety Study of Linagliptin (5 mg), Administered Orally Once Daily for at Least 52 Weeks in Type 2 Diabetic Patients in Combination With Basal Insulin Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2011-09","completion":null,"firstPosted":"2009-08-07","resultsPosted":"2012-09-27","lastUpdate":"2013-12-30"},"enrollment":1263,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Linagliptin","otherNames":[]}],"arms":[{"label":"Linagliptin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to Placebo during long term treatment (52 weeks and longer) in combination with basal insulin in patients with type 2 diabetes mellitus with insufficient glycaemic control.","primaryOutcome":{"measure":"Change From Baseline in HbA1c After 24 Weeks","timeFrame":"Baseline and 24 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.07,"sd":0.08},{"arm":"Linagliptin 5 mg","deltaMin":-0.58,"sd":0.08}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":169,"countries":["United States","Argentina","Belgium","Brazil","Canada","Czechia","Finland","Germany","Greece","Italy","Mexico","Netherlands","Norway","Peru","Russia","Slovakia","South Korea","Spain","Taiwan"]},"refs":{"pmids":["25629790","24062327"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":83,"n":630},"commonTop":["Hypoglycaemia","Hyperglycaemia","Nasopharyngitis","Urinary tract infection","Hypertension"]}}